Pharma Journalist -

Biohaven Pharmaceutical Holding Company Ltd. announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review a New Drug Application (NDA) for zavegepant…
Read More...

Innoviva, Inc. (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and Entasis Therapeutics Holdings Inc.…
Read More...

Medison Pharma a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced the addition of new markets to its…
Read More...

SAE Media Group reports: The return of the Aseptic Processing Conference 2022, taking place in London, UK, on the 19 and 20 September 2022. Due to its first year’s success and the…
Read More...

Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, announced the closing of a $37 million Series A financing led by Kineticos Ventures.…
Read More...

Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cosentyx (secukinumab), used alone…
Read More...

PTC Therapeutics, Inc. announced that Upstaza (eladocagene exuparvovec; PTC-AADC) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the…
Read More...

Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s…
Read More...

Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and…
Read More...

AbbVie announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor…
Read More...